Based on all these findings, we propose that this knowledge may be translated into a personalized treatment strategy (see Figure 3D) that includes screening of pretherapeutic tumor biopsies for the presence of phosphorylated STAT3, followed by a combined treatment with CRT and napabucasin in case of phospho-STAT3 positivity. Here, STAT3 is linked to neoplasm.